144 related articles for article (PubMed ID: 1726333)
21. Granulocytic colony-stimulating factors in the management of patients with acute myeloid leukemia.
Dombret H
Hematol Cell Ther; 1996 Jul; 38(3):231-40. PubMed ID: 8974786
[TBL] [Abstract][Full Text] [Related]
22. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
Lehrnbecher T; Creutzig U
Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia.
Ohno R
Leuk Res; 1998 Dec; 22(12):1143-54. PubMed ID: 9922078
[TBL] [Abstract][Full Text] [Related]
24. Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants.
Giles FJ
Clin Infect Dis; 1998 Jun; 26(6):1282-9. PubMed ID: 9636847
[TBL] [Abstract][Full Text] [Related]
25. Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
Löwenberg B; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Vellenga E; Ossenkoppele GJ; Huijgens PC; Verdonck LF; van der Lelie J; Wielenga JJ; Schouten HC; Gmür J; Gratwohl A; Hess U; Fey MF; van Putten WL
J Clin Oncol; 1997 Dec; 15(12):3496-506. PubMed ID: 9396403
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of myeloid leukemia.
Hoelzer D; Seipelt G
Curr Opin Hematol; 1995 May; 2(3):196-203. PubMed ID: 9371995
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins.
Jedema I; Barge RM; Frankel AE; Willemze R; Falkenburg JH
Exp Hematol; 2004 Feb; 32(2):188-94. PubMed ID: 15102480
[TBL] [Abstract][Full Text] [Related]
28. Use of growth factors during induction therapy for acute myeloid leukemia.
Rowe JM
Leukemia; 1996 Apr; 10 Suppl 1():S40-3. PubMed ID: 8618471
[TBL] [Abstract][Full Text] [Related]
29. Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.
Löwenberg B; Suciu S; Archimbaud E; Ossenkoppele G; Verhoef GE; Vellenga E; Wijermans P; Berneman Z; Dekker AW; Stryckmans P; Schouten H; Jehn U; Muus P; Sonneveld P; Dardenne M; Zittoun R
Blood; 1997 Oct; 90(8):2952-61. PubMed ID: 9376575
[TBL] [Abstract][Full Text] [Related]
30. GM-CSF in the treatment of acute myeloid leukemia.
Hiddemann W; Maschmeyer G; Ludwig WD; Königsmann M; Zühlsdorf M; Wörmann B; Boeckmann A; Agion-Freire E; Innig G; Reuter C
Pathol Biol (Paris); 1992 Nov; 39(9):959. PubMed ID: 1538952
[No Abstract] [Full Text] [Related]
31. [Supportive therapy in cancer treatment with colony stimulating factors and evaluation of their effect].
Ohno R
Gan To Kagaku Ryoho; 1992 Mar; 19(3):308-14. PubMed ID: 1371911
[TBL] [Abstract][Full Text] [Related]
32. Use of hematopoietic growth factors in the treatment of acute myelogenous leukemia.
Ganser A; Heil G
Curr Opin Hematol; 1997 May; 4(3):191-5. PubMed ID: 9209835
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignancies.
Löwenberg B; de Greef GE; Wielenga JJ
Anticancer Drugs; 1993 May; 4 Suppl 1():17-20. PubMed ID: 8347852
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic growth factors in the treatment of acute leukemia.
Estey E
Curr Opin Oncol; 1998 Jan; 10(1):23-30. PubMed ID: 9466481
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acute myeloid leukemia with cytokines: effect on duration of neutropenia and response to infections.
Rowe JM
Clin Infect Dis; 1998 Jun; 26(6):1290-4. PubMed ID: 9636848
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of colony-stimulating factors in acute leukemia.
Holdsworth MT; Mathew P
Ann Pharmacother; 2001 Jan; 35(1):92-108. PubMed ID: 11197591
[TBL] [Abstract][Full Text] [Related]
37. The use of GM-CSF and G-CSF in the treatment of acute leukemias.
Harousseau JL; Wu D
Leuk Lymphoma; 1995 Aug; 18(5-6):405-12. PubMed ID: 8528046
[TBL] [Abstract][Full Text] [Related]
38. Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.
Frumkin LR
Curr Opin Hematol; 1997 May; 4(3):200-6. PubMed ID: 9209837
[TBL] [Abstract][Full Text] [Related]
39. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
Bennett CL; Stinson TJ; Laver JH; Bishop MR; Godwin JE; Tallman MS
Leuk Lymphoma; 2000 Mar; 37(1-2):65-70. PubMed ID: 10721770
[TBL] [Abstract][Full Text] [Related]
40. [Granulo-monocyte growth factors. Their value in pneumonologic oncologic practice].
Trédaniel J; Brice P; Creange A; Lepage E; Lebeau B; Hirsch A
Rev Mal Respir; 1991; 8(1):39-44. PubMed ID: 1709751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
